Literature DB >> 9007316

Asymptomatic and late-onset ornithine transcarbamylase (OTC) deficiency in males of a five-generation family, caused by an A208T mutation.

O P van Diggelen1, J Zaremba, W He, J L Keulemans, A M Boer, A J Reuser, M G Ausems, J A Smeitink, J Kowalczyk, E Pronicka, D Rokicki, E Tarnowska-Dziduszko, A L Kneppers, E Bakker.   

Abstract

In a large five-generation Polish family, late-onset ornithine transcarbamylase (OTC) deficiency in males segregated with the missense mutation Ala208Thr (A208T), and all heterozygous females were asymptomatic. No other mutations were found in the coding sequences and intron-exon boundaries of the OTC gene. Surprisingly, the mutation originated from the great-grandfather of the index patient who died at age 59 of liver carcinoma. He never had dietary restrictions or hyperammonemic spells throughout life and appears to be the oldest male reported with OTC deficiency. The index patient had a severe OTC deficiency (3% of normal). Eight males died suddenly at ages 4 months to 23 years (average 14 years) after a foudroyant episode triggered by a common infection. The patients remained undiagnosed for 28 years because a metabolic defect was not considered to be the cause of the acute episodes. Recognition of the familial pattern of inheritance was initially unnoticed since the patients were admitted to eight different hospitals. DNA analysis predicted that two 'healthy' boys also had OTC deficiency, which was confirmed by abnormal results of allopurinol challenge tests. Initial suspicion of OTC deficiency in such families is complicated, since symptoms can develop at any age, or even remain absent. This obscures the typical pattern of X-linked inheritance in small families.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9007316     DOI: 10.1111/j.1399-0004.1996.tb02380.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

1.  Under recognition of late onset ornithine transcarbamylase deficiency.

Authors:  R E Schultz; M K Salo
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

2.  Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases.

Authors:  Jianbin Peng; Colvin M Redman; Xu Wu; Xiaoling Song; Ruth H Walker; Connie M Westhoff; Soohee Lee
Journal:  Gene       Date:  2007-01-11       Impact factor: 3.688

3.  Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.

Authors:  J A Arranz; E Riudor; C Marco-Marín; V Rubio
Journal:  J Inherit Metab Dis       Date:  2007-03-01       Impact factor: 4.750

4.  Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration.

Authors:  Jordi Gascon-Bayarri; Jaume Campdelacreu; Jordi Estela; Ramon Reñé
Journal:  Case Rep Neurol Med       Date:  2015-04-09

5.  Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment.

Authors:  Catia Cavicchi; Maria Donati; Rossella Parini; Miriam Rigoldi; Mauro Bernardi; Francesca Orfei; Nicolò Gentiloni Silveri; Aniello Colasante; Silvia Funghini; Serena Catarzi; Elisabetta Pasquini; Giancarlo la Marca; Sean Mooney; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2014-07-16       Impact factor: 4.123

6.  Urea Cycle Defects: Early-Onset Disease Associated with A208T Mutation in OTC Gene-Expanding the Clinical Phenotype.

Authors:  Ana Isabel Sánchez; Alejandra Rincón; Mary García; Fernando Suárez-Obando
Journal:  Case Rep Genet       Date:  2017-02-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.